SCHEMBL21362526

SCHEMBL21362526

CCC(C)Cc1cc(Br)c(C(=O)c2ccc(F)cc2)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.35
HPGD P15428 2/20 0.35
ALDH1A1 P00352 1/20 0.35
RXRA P19793 1/20 0.34
DPP4 P27487 2/20 0.34
CYP3A4 P08684 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MAPK1 P28482 2/20 0.33
BCHE P06276 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
TSHR P16473 1/20 0.33
CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21351938 0.83 PTPN1 (0.42) CHRNA7RXRAMAPK1MEN1KMT2A
SCHEMBL21362417 0.81 CHRNA7 (0.38) CHRNA7HPGDALDH1A1LMNAMAPT
SCHEMBL21352204 0.79 CHRNA7 (0.36) CHRNA7RXRAMAPK1LMNATP53
SCHEMBL20158155 0.74 HDAC1 (0.42) HPGDALDH1A1RXRAMAPK1LMNA
SCHEMBL21564810 0.74 MAPK1 (0.39) CHRNA7ALDH1A1RXRAKDM4EMAPK1
SCHEMBL21351833 0.73 RXRA (0.35) CHRNA7RXRAMAPK1BCHELMNA
SCHEMBL20157993 0.72 PTPN1 (0.40) RXRAMAPK1LMNATP53MAPT
SCHEMBL21352150 0.72 ALDH1A1 (0.43) HPGDALDH1A1MAPK1LMNAMAPT
SCHEMBL21351843 0.72 NPC1 (0.34) CHRNA7HPGDALDH1A1RXRALMNA
SCHEMBL21351845 0.72 MEN1 (0.35) CHRNA7ALDH1A1RXRALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed